EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

GPNMB is a novel binding partner of FGFR1 that affects tumorigenic potential through AKT phosphorylation in TNBC

Manar A Elhinnawi iD, Yukari Okita iD, Katsunobu Shigematsu, Mohammed Abdelaziz, Rie Shiratani, Kunio Kawanishi, Kowit Hengphasatporn, Thuy Linh Dang Cao, Yasuteru Shigeta, Mitsuyasu Kato iD

Cancer Science · 2025

DOI: 10.1111/cas.16419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Manar A Elhinnawi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pathology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Triple Negative Breast Neoplasms, Proto-Oncogene Proteins c-akt, Membrane Glycoproteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Science Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a heterogeneous disease and is one of the most prevalent cancers in women. Triple‐negative breast cancer (TNBC) is a relatively aggressive subtype of breast cancer, which is difficult to treat. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a type I transmembrane protein that is overexpressed in various types of cancers, including breast cancer, especially TNBC. In this study, bioinformatic analyses revealed enhanced fibroblast growth factor receptor 1 (FGFR1) signaling in patients with invasive breast cancer, and the GPNMB high / FGFR1 high group exhibited a lower probability of relapse‐free survival (RFS) than the GPNMB low / FGFR1 low group. Additionally, we observed that GPNMB and FGFR1 were essential for sphere formation, cellular migration, and epithelial‐mesenchymal transition (EMT)‐like changes in TNBC cells. To explore the mutual interaction between these two molecules, we conducted in silico protein–protein docking studies and molecular dynamics simulations. The results revealed that GPNMB isoform b exhibits high binding affinity for FGFR1 isoform c (FGFR1c), which correlates with cancer aggressiveness. We also confirmed the interaction between GPNMB and FGFR1 in TNBC cells. Furthermore, our study demonstrated that GPNMB is essential for AKT phosphorylation at T308 following FGF2 stimulation, resulting in high affinity for FGFR1c. Inhibition of AKT phosphorylation substantially reduces the tumorigenic potential of TNBC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1Triple Negative Breast NeoplasmsProto-Oncogene Proteins c-aktMembrane GlycoproteinsHumansFemalePhosphorylationCell Line, TumorEpithelial-Mesenchymal TransitionCell MovementSignal TransductionProtein BindingMolecular Docking SimulationAnimalsMiceCarcinogenesisCell Proliferation

Stichwörter der Autor:innen

cell migrationepithelial–mesenchymal transitionfibroblast growth factor receptor 1glycoprotein nonmetastatic melanoma protein Btriple‐negative breast cancer

Substanzen

Receptor, Fibroblast Growth Factor, Type 1GPNMB protein, humanProto-Oncogene Proteins c-aktFGFR1 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Experimental Pathology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt.
  • Stem Cells Lab Center of Excellence for Advanced Sciences, National Research Centre, Cairo, Egypt.
  • Division of Cell Dynamics, Transborder Medical Research Center, University of Tsukuba, Ibaraki, Japan.
  • Department of Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt.
  • Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan.

ORCID-Profile: Manar A Elhinnawi, Yukari Okita, Mitsuyasu Kato

Förderung

  • Takeda Science Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Elhinnawi, M. A., Okita, Y., Shigematsu, K., Abdelaziz, M., Shiratani, R., Kawanishi, K., Hengphasatporn, K., Dang Cao, T. L., Shigeta, Y., & Kato, M. (2025). GPNMB is a novel binding partner of FGFR1 that affects tumorigenic potential through AKT phosphorylation in TNBC. Cancer Science. https://doi.org/10.1111/cas.16419

Vancouver

Elhinnawi MA, Okita Y, Shigematsu K, Abdelaziz M, Shiratani R, Kawanishi K, et al. GPNMB is a novel binding partner of FGFR1 that affects tumorigenic potential through AKT phosphorylation in TNBC. Cancer Science. 2025. doi:10.1111/cas.16419

BibTeX
@article{Elhinnawi2025,
  author = {Elhinnawi, Manar A and Okita, Yukari and Shigematsu, Katsunobu and Abdelaziz, Mohammed and Shiratani, Rie and Kawanishi, Kunio and Hengphasatporn, Kowit and Dang Cao, Thuy Linh and Shigeta, Yasuteru and Kato, Mitsuyasu},
  title = {GPNMB is a novel binding partner of FGFR1 that affects tumorigenic potential through AKT phosphorylation in TNBC},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.16419}
}
Kostenlos starten →